Ethical considerations
This study was approved by the Iranian Registry of Clinical Trials (IRCTID: IRCT20220108053665N1). The treatment steps and the process of patient participation in the study were explained to the patients by the researcher. Patients also signed an informed consent form, which included explanations about the study and the patient's voluntary participation. The researcher reassured patients about protecting their personal information, and patients were allowed to leave the study at any time without giving a specific reason.